Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder

Next Previous
Trial Profile

A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 26 Dec 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Bipolar I disorders
  • Focus Adverse reactions; Registrational
  • Acronyms ATLAS
  • Sponsors Otsuka Pharmaceutical Development & Commercialization

Most Recent Events

  • 09 Oct 2018 Results assessing functional recovery and symptomatic remission after maintenance treatment with aripiprazole once-monthly in patients with bipolar I disorder, presented at the 31st Annual Congress of the European College of Neuropsychopharmacology
  • 04 May 2017 Status changed from recruiting to completed.
  • 08 Oct 2015 Planned number of patients changed from 1000 to 755 as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top